Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positively charged proteins in damaged mucosa represent a physiological target for cytoprotective agents used in the treatment of acid-peptic disorders (StatPearls, 2023). In conditions such as peptic ulcer disease or erosive gastritis, the protective epithelial layer is breached, exposing underlying proteins like albumin and fibrinogen that carry a net positive charge in the acidic environment of the stomach (PubChem). These proteins serve as an electrostatic anchor for polyanionic drugs like sucralfate, which polymerize into a sticky, gel-like substance (Goodman & Gilman, 2018). This interaction forms a physical barrier over the ulcerated area, shielding the sensitive tissue from aggressive factors including hydrochloric acid, pepsin, and bile acids. By isolating the damaged site, this mechanism facilitates the natural healing process and prevents further erosion of the mucosal lining. While not a single receptor, this collection of proteins is a critical pharmacological target for localized, non-systemic therapy in gastroenterology.
Sucralfate undergoes polymerization in an acidic environment (pH < 4) to form a viscous, negatively charged paste that electrostatically binds to positively charged proteins (such as albumin and fibrinogen) exposed in the damaged mucosa or ulcer base (StatPearls, 2023).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Positively charged proteins in damaged mucosa.